Oncotarget: E6-specific inhibitors as therapeutics for HPV+ head and neck carcinomas
'Head and neck squamous cell carcinomas (HNSCC) are heterogeneous tumors that arise in the upper respiratory tract and are the 6th most common cancer worldwide by incidence'
2021-06-02
(Press-News.org) Oncotarget published "A high-content AlphaScreen™ identifies E6-specific small molecule inhibitors as potential therapeutics for HPV+ head and neck squamous cell carcinomas" which reported that the incidence of human papillomavirus-positive head and neck squamous cell carcinoma has increased dramatically over the past decades due to an increase in infection of the oral mucosa by HPV.
The etiology of HPV -HNSCC is linked to expression of the HPV oncoprotein, E6, which influences tumor formation, growth and survival.
E6 effects this oncogenic phenotype in part through inhibitory protein-protein interactions and accelerated degradation of proteins with tumor suppressor properties, such as p53 and caspase 8. Interfering with the binding between E6 and its cellular partners may therefore represent a reasonable pharmacological intervention in HPV tumors.
In this study, the authors probed a small-molecule library using AlphaScreen™ technology to discover novel E6 inhibitors.
Further testing of this analog in a panel of HPV and HPV– cell lines showed good potency and a large window of selectivity as demonstrated by apoptosis induction and significant inhibition of cell growth, cell survival in HPV cells.
Dr. Penelope J. Duerksen-Hughes from The Loma Linda University said, "Head and neck squamous cell carcinomas (HNSCC) are heterogeneous tumors that arise in the upper respiratory tract and are the 6th most common cancer worldwide by incidence."
"Head and neck squamous cell carcinomas (HNSCC) are heterogeneous tumors that arise in the upper respiratory tract and are the 6th most common cancer worldwide by incidence."
In parallel, HPV -HNSCC, which is caused by HPV, has risen dramatically within the same period.
Compared to its HPV- counterpart, HPV -HNSCC carries a more favorable prognosis and is more prevalent in younger and otherwise healthier patients.
HPV oncoproteins, particularly E6, represent a unique and potentially therapeutically favorable strategic approach for targeted HPV -HNSCC treatment.
These findings are corroborated by findings that have shown that the absence of p53 and caspase 8 in HNSCC is correlated with attenuation of sensitivity of HPV -HNSCC to chemotherapy and radiation.
Consistent with this, genetic tools such as CRISPER, TALEN gene knockouts, RNAi and other agents that indirectly knock down E6 mRNA have demonstrated that depleting the protein abundance of E6 leads to anti-proliferative effects and enhances the response of HPV cells to chemotherapy agents and radiation.
The Duerksen-Hughes Research Team concluded in their Oncotarget Research Output, "the evidence we have gathered suggests that GA-OH can serve as a basis for better understanding the mechanism of E6 inhibition, and has the potential for further development to improve potency and drug-likeness. Tools such as computational modelling and medicinal chemistry can utilize this inhibitor as a good starting point for optimization and in understanding important interactions between E6 and its inhibitors."
INFORMATION:
DOI - https://doi.org/10.18632/oncotarget.27908
Full text - https://www.oncotarget.com/article/27908/text/
Correspondence to - Penelope J. Duerksen-Hughes - pdhughes@llu.edu
Keywords -
HNSCC,
HPV,
E6,
AlphaScreen™,
30-hydroxygambogic acid
About Oncotarget
Oncotarget is a bi-weekly, peer-reviewed, open access biomedical journal covering research on all aspects of oncology.
To learn more about Oncotarget, please visit https://www.oncotarget.com or connect with:
SoundCloud - https://soundcloud.com/oncotarget
Facebook - https://www.facebook.com/Oncotarget/
Twitter - https://twitter.com/oncotarget
LinkedIn - https://www.linkedin.com/company/oncotarget
Pinterest - https://www.pinterest.com/oncotarget/
Reddit - https://www.reddit.com/user/Oncotarget/
Oncotarget is published by Impact Journals, LLC please visit https://www.ImpactJournals.com or connect with @ImpactJrnls
Media Contact
MEDIA@IMPACTJOURNALS.COM
18009220957x105
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2021-06-02
Oncotarget published "Molecular characterization of lung squamous cell carcinoma tumors reveals therapeutically relevant alterations" which reported that unlike lung adenocarcinoma patients, there is no FDA-approved targeted-therapy likely to benefit lung squamous cell carcinoma patients.
The authors performed survival analyses of lung squamous cell carcinoma patients harboring therapeutically relevant alterations identified by whole exome sequencing and mass spectrometry-based validation across 430 lung squamous tumors.
They report a mean of 11.6 mutations/Mb with a characteristic smoking signature along with mutations in TP53, CDKN2A, NFE2L2, FAT1, KMT2C, LRP1B, FGFR1, PTEN and PREX2 among lung squamous cell carcinoma patients of Indian descent.
In overall, the data suggests 13.5% ...
2021-06-02
When the COVID-19 pandemic arrived in North America in March 2020, health care facilities stopped providing all but "essential" care, to reduce infection risks and preserve protective gear known as PPE.
That included changes at many centers that provide ECT (electroconvulsive therapy) for severe depression and other conditions, a new survey shows.
Because ECT involves anesthesia, so that patients are unconscious when carefully controlled pulses of electricity are delivered to key areas of the brain, it is considered an 'aerosol generating' procedure. That means it poses special risks when a respiratory ...
2021-06-02
* ICFO researchers report in Nature on having achieved, for the first time, entanglement of two multimode quantum memories located in different labs separated by 10 meters, and heralded by a photon at the telecommunication wavelength.
* The scientists implemented a technique that allowed them to reach a record in the entanglement rate in a system that could be integrated into the fibre communication network, paving the way to operation over long distances.
* The results are considered a landmark for quantum communications and a major step forward in the development of quantum repeaters for the future quantum internet.
During the 90s, engineers made major advances in the telecom arena spreading out the network to distances beyond the ...
2021-06-02
TROY, N.Y. -- Oxygen levels in the world's temperate freshwater lakes are declining rapidly -- faster than in the oceans -- a trend driven largely by climate change that threatens freshwater biodiversity and drinking water quality.
Research published today in Nature found that oxygen levels in surveyed lakes across the temperate zone have declined 5.5% at the surface and 18.6% in deep waters since 1980. Meanwhile, in a large subset of mostly nutrient-polluted lakes, surface oxygen levels increased as water temperatures crossed a threshold favoring cyanobacteria, which can create toxins when they flourish in the form of harmful algal blooms.
"All complex life depends on oxygen. It's the support system for aquatic food webs. And when you start losing oxygen, you have the potential ...
2021-06-02
Chinese researchers realized an elementary link of a quantum repeater based on absorptive quantum memories (QMs) and demonstrated the multiplexed quantum repeater for the first time. On June 2nd?the work is published in Nature.
The fundamental task of a quantum network is to distribute quantum entanglement between two remote locations. However, the transmission loss of optical fiber has limited the distance of entanglement distribution to approximately 100 km on the ground. Quantum repeaters can overcome this difficulty by dividing long-distance transmission into several short-distance elementary links. The entanglement of two end nodes of each link is created firstly. Then the entanglement distance is gradually expanded through entanglement swapping between each link.
Previously, an ...
2021-06-02
HOUSTON - (June 2, 2021) - It's official: Hexagonal boron nitride (h-BN) is the iron man of 2D materials, so resistant to cracking that it defies a century-old theoretical description engineers still use to measure toughness.
"What we observed in this material is remarkable," said Rice University's Jun Lou, co-corresponding author of a Nature paper published this week. "Nobody expected to see this in 2D materials. That's why it's so exciting."
Lou explains the significance of the discovery by comparing the fracture toughness of h-BN with that of its better-known cousin ...
2021-06-02
The study, published in the journal Nature, shows how a drug available on the NHS can boost fitness of healthy stem cells in the gut, making them more resistant to sabotage from mutant stem cells that cause cancer.
Researchers in the Netherlands, funded by the UK charity Worldwide Cancer Research, have discovered a way to boost the fitness of healthy cells in the gut to prevent the development of bowel cancer. The findings have led to the initiation of a clinical trial to find out if a commonly used psychiatric drug could be used to prevent bowel cancer in people. The trial will recruit patients with a genetic mutation that means they are virtually 100% certain to develop bowel cancer in their lifetime, unless ...
2021-06-02
Metastases can develop in the body even years after apparently successful cancer treatment. They originate from cancer cells that migrated from the original tumor to other organs, and which can lie there inactive for a considerable time. Researchers have now discovered how these "sleeping cells" are kept dormant and how they wake up and form fatal metastases. They have reported their findings in the journal Nature.
A tumor can leave behind an ominous legacy in the body: cancer cells can migrate from the tumor to other tissues in the body, where they survive after treatment in a kind of hibernation called dormancy. Currently, cancer medicine relies on monitoring cancer patients ...
2021-06-02
Studies on cancer are limited by the threshold at which cellular transformations become clinically detectable. However, the very initial phase on the way to malignancy is histologically invisible, as the process originates from one single cell. In this early phase, a so-called "seeding cell" acquires an initial pro-cancerous mutation, also known as the "first oncogenic hit", while being completely surrounded by normal tissue. To overcome the detection barrier, a team of researchers around IMBA group leader Bon-Kyoung Koo and University of Cambridge group leader Professor Benjamin D. Simons developed a laboratory system to dissect the pre-cancerous steps that remained under the radar ...
2021-06-02
A team of researchers led by the University of Cambridge and University of Utrecht examined trends in daily crime counts before and after COVID-19 restrictions were implemented in major metropolitan areas such as Barcelona, Chicago, Sao Paulo, Tel Aviv, Brisbane and London.
While both stringency of lockdowns and the resulting crime reductions varied considerably from city to city, the researchers found that most types of crime - with the key exception of homicide - fell significantly in the study sites.
Across all 27 cities, daily assaults fell ...
LAST 30 PRESS RELEASES:
[Press-News.org] Oncotarget: E6-specific inhibitors as therapeutics for HPV+ head and neck carcinomas
'Head and neck squamous cell carcinomas (HNSCC) are heterogeneous tumors that arise in the upper respiratory tract and are the 6th most common cancer worldwide by incidence'
